We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+0.77%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$8.45B
AUM Growth
+$114M
Cap. Flow
-$238M
Cap. Flow %
-2.82%
Top 10 Hldgs %
27.25%
Holding
2,646
New
712
Increased
589
Reduced
740
Closed
529

Sector Composition

Rank Sector Weight
1 Financials 5.47%
2 Industrials 4.7%
3 Technology 4.5%
4 Healthcare 3.5%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTO icon
2026
Alto Ingredients
ALTO
$349M
$144K ﹤0.01%
22,961
-23,502
-51% -$153K
RGLS
2027
DELISTED
Regulus Therapeutics
RGLS
$144K ﹤0.01%
+1,217
New +$203K
WT icon
2028
WisdomTree
WT
$3B
$142K ﹤0.01%
13,908
-18,694
-57% -$173K
AES icon
2029
AES
AES
$10.6B
$140K ﹤0.01%
12,574
-97,293
-89% -$1.12M
KAACW
2030
DELISTED
Kayne Anderson Acquisition Corp.
KAACW
$139K ﹤0.01%
+166,666
New +$146K
KA
2031
DELISTED
Kineta, Inc. Common Stock
KA
$137K ﹤0.01%
+209
New +$149K
VSI
2032
DELISTED
Vitamin Shoppe Inc.
VSI
$137K ﹤0.01%
+11,800
New +$174K
TTNP
2033
DELISTED
Titan Pharmaceuticals
TTNP
$136K ﹤0.01%
+20
New +$186K
IOVA icon
2034
Iovance Biotherapeutics
IOVA
$2.22B
$135K ﹤0.01%
+18,400
New +$117K
EIGI
2035
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$135K ﹤0.01%
+16,091
New +$125K
NPTN
2036
DELISTED
NEOPHOTONICS CORP
NPTN
$132K ﹤0.01%
17,223
+5,792
+51% +$48.9K
GNMX
2037
DELISTED
Aevi Genomic Medicine Inc
GNMX
$131K ﹤0.01%
+98,300
New +$142K
TDW icon
2038
Tidewater
TDW
$3.93B
$128K ﹤0.01%
5,509
+4,458
+424% +$120K
IRMD icon
2039
iRadimed
IRMD
$1.21B
$126K ﹤0.01%
+14,700
New +$125K
BPTH
2040
DELISTED
Bio-Path Holdings Inc
BPTH
$125K ﹤0.01%
+81
New +$170K
EIGR
2041
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$123K ﹤0.01%
+520
New +$118K
PSTB
2042
DELISTED
Park Sterling Corp.
PSTB
$123K ﹤0.01%
+10,357
New +$123K
AUY
2043
DELISTED
Yamana Gold, Inc.
AUY
$122K ﹤0.01%
+50,696
New +$137K
APVO icon
2044
Aptevo Therapeutics
APVO
$5.35M
0
CHRD icon
2045
Chord Energy
CHRD
$7.47B
$121K ﹤0.01%
+15,041
New +$165K
TCS
2046
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$121K ﹤0.01%
+1,366
New +$98.1K
RCKT icon
2047
Rocket Pharmaceuticals
RCKT
$359M
$119K ﹤0.01%
+15,675
New +$117K
DS
2048
DELISTED
Drive Shack Inc.
DS
$118K ﹤0.01%
+37,400
New +$135K
MORE
2049
DELISTED
Monogram Residential Trust, Inc.
MORE
$118K ﹤0.01%
+12,100
New +$120K
KDMN
2050
DELISTED
Kadmon Holdings, Inc.
KDMN
$117K ﹤0.01%
+30,000
New +$84.9K

Similar funds

Paloma Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Paloma Partners held 2,646 positions worth $8.45B, up 1.4% from $8.33B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Paloma Partners's Q2 2017 filing shows 712 new, 589 increased, 740 reduced and 529 closed positions. Its largest new stake was Civitas Resources: 1,180,989 shares worth $37.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $75.8M.

By sector, the portfolio is most concentrated in Financials at 5.5% of assets, up from 3.4% a quarter earlier, followed by Industrials and Technology.

  • Paloma Partners's largest Q2 2017 buy was Civitas Resources: 1,180,989 shares worth $37.4M.
  • Paloma Partners added most to State Street Technology Select Sector SPDR ETF in Q2 2017, an estimated $69M increase.
  • Paloma Partners's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $75.8M.
  • Paloma Partners fully exited Yahoo Inc in Q2 2017, selling an estimated $26.2M.
  • Paloma Partners's ten largest holdings make up 27% of its $8.45B portfolio in Q2 2017.
  • Paloma Partners opened 712 new positions and closed 529 in Q2 2017.
  • Paloma Partners's portfolio value rose 1.4% quarter-over-quarter to $8.45B.

Based on Paloma Partners's 13F filing for Q2 2017, filed 14 Aug 2017.